Sernova is a regenerative medicine company focused on developing innovative therapeutic technologies aimed at treating chronic diseases such as insulin-dependent diabetes, hemophilia A, and thyroid disease. Central to their approach is the Cell Pouch System™, an implantable medical device designed to create a vascularized environment that supports the long-term survival and function of therapeutic cells. These cells are engineered to produce and release essential proteins or hormones that the body lacks, thereby providing an alternative to daily medication regimens. The Cell Pouch System™ has demonstrated safety and efficacy in preclinical studies and is currently undergoing clinical trials, particularly for diabetes treatment.

In addition to the Cell Pouch System™, Sernova employs Immune Protection Technology to safeguard therapeutic cells from immune system attacks. This is achieved through microencapsulation techniques that house the cells within the Cell Pouch, allowing for nutrient and insulin flow while preventing immune rejection. Ongoing developments aim to make transplanted cells unrecognizable to the immune system, further enhancing the safety and effectiveness of the treatment. By combining these technologies, Sernova aims to offer a long-term, safe, and convenient therapeutic option for patients with chronic diseases, ultimately improving their quality of life.

Canada

Sernova (TSX: SVA) (OTCQB: SEOVF) is a clinical-stage biotechnology company that is advancing a novel cell therapy platform for the treatment of chronic diseases. Our lead program is evaluating our Cell Pouch System™ as a potential ‘functional cure’ for insulin-dependent diabetes. In addition, we have a robust pipeline that includes preclinical programs in hemophilia A and hypothyroidism. 

Endocrine System Diseases

Genetic Diseases

Hematologic Diseases

Metabolic Diseases

Sernova Biotherapeutics

Diabetes

Human Donor Islets

Biologics

Cell Therapies

Micro-encapsulated islets

Micro-encapsulated stem cell derived cells

Hemophilia

Corrected patient cells

Devices

Implants

Lentiviral Vector (LVV)

Regenerative Medicine

Therapeutic

Sernova Biotherapeutics

Company Details